Additionally, MCI participants exhibited slower response rates for the 2-target and 3-target trials compared to the nonimpaired controls, although this difference was only marginally significant.
← all excerpts
Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer's disease.
1
—
—